Peptonic Medical
0.00 SEK
0.00 %
Less than 1K followers
PMED
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
0.00 %
+9.09 %
+50.00 %
0.00 %
-36.84 %
-45.45 %
-96.78 %
-99.70 %
-99.86 %
Peptonic Medical is a pharmaceutical company. Currently, the focus is on the treatment of female vaginal atrophy. The company offers a treatment free from oestrogen, where the products contain the oxytocin hormone. A large part of the projects is carried out in collaboration with other industry players. The main business is found on the Nordic market. The company is based in Bromma.
Read moreMarket cap
22.41M SEK
Turnover
80.58K SEK
Revenue
26.89M
EBIT %
-218.11 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
25/2
2026
Annual report '25
All
Press releases
ShowingAll content types
PEPTONIC Medical AB: Peptonic Medical AB's reconstruction plan approved by the Uppsala District Court
PEPTONIC Medical AB: Peptonic Medical AB:s rekonstruktionsplan godkänns av Uppsala tingsrätt
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools